$XELB
XCel Brands, Inc.

2021 Q4 Form 10-K Financial Statement

#000155837022005491 Filed on April 15, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $8.098M $37.93M $7.480M
YoY Change 8.26% 28.81% -34.15%
Cost Of Revenue $2.904M $10.67M $1.530M
YoY Change 89.8% 95.51% -58.87%
Gross Profit $5.194M $27.27M $5.950M
YoY Change -12.71% 13.64% -22.02%
Gross Profit Margin 64.14% 71.88% 79.55%
Selling, General & Admin $8.988M $14.36M $5.870M
YoY Change 53.12% 47.43% -7.56%
% of Gross Profit 173.05% 52.68% 98.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.881M $6.830M $1.430M
YoY Change 31.54% 24.25% 48.96%
% of Gross Profit 36.21% 25.05% 24.03%
Operating Expenses $10.87M $14.36M $7.300M
YoY Change 48.89% 47.43% -0.14%
Operating Profit -$5.675M -$12.56M -$1.350M
YoY Change 320.37% -23.49% -521.87%
Interest Expense -$573.0K -$2.063M -$300.0K
YoY Change 91.0% 73.36% -6.25%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.315M -$16.14M -$14.70M
YoY Change -43.44% -8.34% 102.76%
Income Tax -$1.087M -$3.106M -$4.250M
% Of Pretax Income
Net Earnings -$6.943M -$12.18M -$10.40M
YoY Change -33.24% -5.81% 95.86%
Net Earnings / Revenue -85.74% -32.12% -139.04%
Basic Earnings Per Share -$0.63
Diluted Earnings Per Share -$354.8K -$0.63 -$540.8K
COMMON SHARES
Basic Shares Outstanding 19.56M 19.46M
Diluted Shares Outstanding 19.46M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.483M $4.483M $5.000M
YoY Change -10.34% -10.34% 8.7%
Cash & Equivalents $4.483M $4.483M $4.957M
Short-Term Investments
Other Short-Term Assets $1.681M $1.681M $1.100M
YoY Change 52.82% 52.82% -21.43%
Inventory $3.375M $3.375M $1.216M
Prepaid Expenses
Receivables $7.640M $7.640M $8.900M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.18M $17.18M $16.15M
YoY Change 6.39% 6.7% -8.26%
LONG-TERM ASSETS
Property, Plant & Equipment $2.549M $8.863M $3.367M
YoY Change -24.29% -26.14% -73.9%
Goodwill
YoY Change
Intangibles $98.30M $93.54M
YoY Change 5.1%
Long-Term Investments
YoY Change
Other Assets $555.0K $1.435M $228.0K
YoY Change 143.42% 10.38% -85.75%
Total Long-Term Assets $108.6M $108.6M $106.9M
YoY Change 1.59% 1.5% -14.88%
TOTAL ASSETS
Total Short-Term Assets $17.18M $17.18M $16.15M
Total Long-Term Assets $108.6M $108.6M $106.9M
Total Assets $125.8M $125.8M $123.1M
YoY Change 2.22% 2.18% -14.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.233M $6.233M $4.400M
YoY Change 41.66% 41.66% 0.0%
Accrued Expenses $1.784M $1.784M $3.100M
YoY Change -42.45% -42.45% -3.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.500M $2.500M $2.800M
YoY Change -10.71% -10.71% 21.74%
Total Short-Term Liabilities $10.52M $10.52M $10.32M
YoY Change 1.95% 2.11% 5.27%
LONG-TERM LIABILITIES
Long-Term Debt $25.53M $25.53M $13.84M
YoY Change 84.5% 85.01% -16.64%
Other Long-Term Liabilities $14.79M $14.79M $200.0K
YoY Change 7295.5% 54.07% -98.17%
Total Long-Term Liabilities $40.32M $40.32M $26.48M
YoY Change 52.26% 72.32% -3.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.52M $10.52M $10.32M
Total Long-Term Liabilities $40.32M $40.32M $26.48M
Total Liabilities $50.84M $51.50M $36.80M
YoY Change 38.15% 38.07% -18.41%
SHAREHOLDERS EQUITY
Retained Earnings -$28.78M -$16.60M
YoY Change 73.37%
Common Stock $20.00K $19.00K
YoY Change 5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $74.28M $74.28M $85.75M
YoY Change
Total Liabilities & Shareholders Equity $125.8M $125.8M $123.1M
YoY Change 2.22% 2.18% -14.07%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$6.943M -$12.18M -$10.40M
YoY Change -33.24% -5.81% 95.86%
Depreciation, Depletion And Amortization $1.881M $6.830M $1.430M
YoY Change 31.54% 24.25% 48.96%
Cash From Operating Activities -$1.027M -$6.556M $990.0K
YoY Change -203.74% -305.84% 102.04%
INVESTING ACTIVITIES
Capital Expenditures -$46.00K $1.095M -$50.00K
YoY Change -8.0% 46.39% -76.19%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$3.661M $0.00
YoY Change -7422.0% -100.0%
Cash From Investing Activities -$46.00K -$4.795M -$50.00K
YoY Change -8.0% 583.05% -91.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $16.00K
YoY Change -91.58%
Debt Paid & Issued, Net $41.75M
YoY Change 1755.56%
Cash From Financing Activities 1.575M 10.51M -760.0K
YoY Change -307.24% -584.86% -33.91%
NET CHANGE
Cash From Operating Activities -1.027M -6.556M 990.0K
Cash From Investing Activities -46.00K -4.795M -50.00K
Cash From Financing Activities 1.575M 10.51M -760.0K
Net Change In Cash 502.0K -844.0K 180.0K
YoY Change 178.89% -367.09% -114.4%
FREE CASH FLOW
Cash From Operating Activities -$1.027M -$6.556M $990.0K
Capital Expenditures -$46.00K $1.095M -$50.00K
Free Cash Flow -$981.0K -$7.651M $1.040M
YoY Change -194.33% -413.95% 48.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19455987
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19117460
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19571119
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1085000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19260862
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001083220
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-37527
CY2021 dei Entity Registrant Name
EntityRegistrantName
XCEL BRANDS, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0307819
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1333 Broadway, 10th Floor
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
CY2021 dei City Area Code
CityAreaCode
347
CY2021 dei Local Phone Number
LocalPhoneNumber
727-2474
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2021 dei Trading Symbol
TradingSymbol
XELB
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
32782040
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19571119
CY2021 dei Auditor Firm
AuditorFirmId
688
CY2020 dei Auditor Firm
AuditorFirmId
596
CY2021 dei Auditor Name
AuditorName
Marcum LLP
CY2021 dei Auditor Location
AuditorLocation
New York, NY
CY2020 dei Auditor Name
AuditorName
CohnReznick LLP
CY2020 dei Auditor Location
AuditorLocation
New York, New York
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4483000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4957000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1090000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1151000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7640000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8889000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3375000
CY2020Q4 us-gaap Inventory Net
InventoryNet
1216000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1681000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
17179000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
16147000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2549000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3367000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6314000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8668000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
98304000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
93535000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
739000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1109000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
141000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
555000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
228000
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
108602000
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
106907000
CY2021Q4 us-gaap Assets
Assets
125781000
CY2020Q4 us-gaap Assets
Assets
123054000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6233000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4442000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
577000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
973000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1207000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2101000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2800000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10517000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10316000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7252000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8469000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25531000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13838000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7539000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
900000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3052000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
224000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
40322000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
26483000
CY2021Q4 us-gaap Liabilities
Liabilities
50839000
CY2020Q4 us-gaap Liabilities
Liabilities
36799000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020 xelb Government Grant Reduction Of Expenses
GovernmentGrantReductionOfExpenses
1816000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19571119
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19260862
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103039000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102324000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28779000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16595000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
74280000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
85748000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
662000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
507000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
74942000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
86255000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125781000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
123054000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
37932000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
29448000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10667000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5456000
CY2021 us-gaap Gross Profit
GrossProfit
27265000
CY2020 us-gaap Gross Profit
GrossProfit
23992000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
16535000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13061000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14364000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9743000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
720000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
850000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6830000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5497000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1372000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
13113000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
39821000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
40448000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
46000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-12556000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-16410000
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
1916000
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
1220000
CY2021 xelb Other Interest And Finance Charges Income Net
OtherInterestAndFinanceChargesIncomeNet
147000
CY2020 xelb Other Interest And Finance Charges Income Net
OtherInterestAndFinanceChargesIncomeNet
-27000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1516000
CY2021 us-gaap Interest And Debt Expense
InterestAndDebtExpense
3579000
CY2020 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1193000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16135000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17603000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3106000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4518000
CY2021 us-gaap Profit Loss
ProfitLoss
-13029000
CY2020 us-gaap Profit Loss
ProfitLoss
-13085000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-845000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-149000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-12184000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-12936000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19455987
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19117460
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
98452000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
257000
CY2020 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
300000
CY2020 us-gaap Profit Loss
ProfitLoss
-13085000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
86255000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
343000
CY2021 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
1000000
CY2021 us-gaap Profit Loss
ProfitLoss
-13029000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
74942000
CY2021 us-gaap Profit Loss
ProfitLoss
-13029000
CY2020 us-gaap Profit Loss
ProfitLoss
-13085000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6830000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5497000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1372000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
13113000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
308000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
95000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
720000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
850000
CY2021 xelb Allowance For Doubtful Accounts Receivable Write Off And Expense
AllowanceForDoubtfulAccountsReceivableWriteOffAndExpense
102000
CY2020 xelb Allowance For Doubtful Accounts Receivable Write Off And Expense
AllowanceForDoubtfulAccountsReceivableWriteOffAndExpense
1042000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1516000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3192000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4382000
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
46000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1147000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-691000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2159000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
317000
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
818000
CY2020 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-597000
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1228000
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-496000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-581000
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-374000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6556000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3185000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3661000
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
46000
CY2021 xelb Payments To Acquire Other Intangible Assets
PaymentsToAcquireOtherIntangibleAssets
39000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1095000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
748000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4795000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-702000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
190000
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1000000
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
300000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2498000
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
54000000
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2173000
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
27000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2498000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
41750000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2250000
CY2021 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
559000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10507000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2167000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-844000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
316000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6066000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5750000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5222000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6066000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4483000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4957000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
739000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1109000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5222000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6066000
CY2020 xelb Operating Lease Right Of Use Asset Non Cash
OperatingLeaseRightOfUseAssetNonCash
797000
CY2020 xelb Operating Lease Liability Non Cash
OperatingLeaseLiabilityNonCash
797000
CY2021 xelb Contingent Obligation Of Assets Acquired At Fair Value
ContingentObligationOfAssetsAcquiredAtFairValue
6639000
CY2021 xelb Liability For Equity Based Bonuses
LiabilityForEquityBasedBonuses
-13000
CY2020 xelb Liability For Equity Based Bonuses
LiabilityForEquityBasedBonuses
71000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1799000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1128000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
91000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
58000
CY2021 us-gaap Profit Loss
ProfitLoss
-13000000.0
CY2020 us-gaap Profit Loss
ProfitLoss
-13100000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28800000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16600000
CY2020Q4 xelb Working Capital Net
WorkingCapitalNet
7900000
CY2021Q4 xelb Working Capital Net
WorkingCapitalNet
7900000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4500000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company deems the following items to require significant estimates from management:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Allowance for doubtful accounts;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Useful lives of trademarks;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Assumptions used in the valuation of intangible assets, including cash flow estimates for initial determinations of fair value and/or impairment analysis;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Black-Scholes option pricing model assumptions for the grant date fair value of stock options;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Incremental borrowing rate; </div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Inventory reserves; and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Valuation allowances and effective tax rate for tax purposes.</div><div style="margin-top:12pt;"/>
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">Certain reclassifications have been made to Prior Year financial statements to conform to classifications used in the Current Year – specifically, the classification and aggregation / disaggregation of certain types of operating costs and expenses, and the disaggregation of the components of interest and finance expense. These reclassifications had no impact on total operating costs and expenses, total interest and finance expense, net loss, stockholders’ equity, or cash flows as previously reported.</span></p>
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7600000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8900000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1100000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1200000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
100000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1100000
CY2020Q4 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
0
CY2021Q4 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
0
CY2021 us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
1300000
CY2020 us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
900000
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
700000
CY2021 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
700000
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
100000
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
1100000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
700000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
100000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
100000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
2500000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
900000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash, cash equivalents, and restricted cash balances with high quality financial institutions. At times, the Company’s cash, cash equivalents, and restricted cash may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are minimal due to the collection history and due to the nature of the Company’s royalty revenues. Generally, the Company does not require collateral or other security to support accounts receivable.</p>
CY2021Q2 xelb Asset Acquisition Cash Consideration Paid Subsequent To Closing
AssetAcquisitionCashConsiderationPaidSubsequentToClosing
2000000.0
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
114371000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16067000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
98304000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
104032000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10497000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
93535000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5600000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4600000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6134000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6134000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6120000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4184000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3514000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
27718000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
53804000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
29000000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
16750000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
969000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
112000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
28031000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
16638000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2800000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25531000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13838000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
200000
CY2020 xelb Government Grant Reduction Of Expenses
GovernmentGrantReductionOfExpenses
1800000
CY2021Q4 xelb Capital Stock Authorized
CapitalStockAuthorized
51000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
720000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
850000
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9747035
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0625
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1700000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
1500000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19455987
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19117460
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19455987
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19117460
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5747035
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7759190
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
2047000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1986000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
68000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
81000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
178000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
98000
CY2021 us-gaap Sublease Income
SubleaseIncome
622000
CY2020 us-gaap Sublease Income
SubleaseIncome
618000
CY2021 us-gaap Lease Cost
LeaseCost
1671000
CY2020 us-gaap Lease Cost
LeaseCost
1547000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2000000.0
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1900000
CY2021 us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
700000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-816000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-844000
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3192000
CY2020 us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
700000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1700000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1711000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1711000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1711000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1710000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1610000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10153000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1694000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8459000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1207000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7252000
CY2021Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
2366000
CY2021Q4 xelb Contractual Obligation Due After Next Twelve Months
ContractualObligationDueAfterNextTwelveMonths
0
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
2366000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-202000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
86000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
66000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
86000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-136000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2376000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3538000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
-0.0004
CY2021 xelb Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackPercent
0
CY2020 xelb Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackPercent
0.0056
CY2021 xelb Effective Income Tax Rate Reconciliation Paycheck Protection Program Addback
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramAddback
0
CY2020 xelb Effective Income Tax Rate Reconciliation Paycheck Protection Program Addback
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramAddback
0.0218
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0006
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4382000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3106000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4518000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0464
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0454
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0556
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0194
CY2021 xelb Excess Compensation Deduction
ExcessCompensationDeduction
-0.0068
CY2020 xelb Excess Compensation Deduction
ExcessCompensationDeduction
-0.0051
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
-0.0011
CY2021 xelb Effective Income Tax Rate Reconciliation Federal True Ups Percent
EffectiveIncomeTaxRateReconciliationFederalTrueUpsPercent
-0.0010
CY2020 xelb Effective Income Tax Rate Reconciliation Federal True Ups Percent
EffectiveIncomeTaxRateReconciliationFederalTrueUpsPercent
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
-0.0010
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0001
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1925
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2589
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1274000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2440000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6684000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2907000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
728000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
664000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
309000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
329000
CY2021Q4 xelb Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Basis Difference Arising From Discounted Note Payable
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBasisDifferenceArisingFromDiscountedNotePayable
11000
CY2020Q4 xelb Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Basis Difference Arising From Discounted Note Payable
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBasisDifferenceArisingFromDiscountedNotePayable
11000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
219000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
219000
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
77000
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
63000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
488000
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
321000
CY2021Q4 xelb Deferred Tax Assets Interest Expenses
DeferredTaxAssetsInterestExpenses
602000
CY2020Q4 xelb Deferred Tax Assets Interest Expenses
DeferredTaxAssetsInterestExpenses
0
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10392000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6954000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
10251000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
10006000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10251000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10006000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
141000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3052000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
23700000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
10100000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
300000

Files In Submission

Name View Source Status
0001558370-22-005491-index-headers.html Edgar Link pending
0001558370-22-005491-index.html Edgar Link pending
0001558370-22-005491.txt Edgar Link pending
0001558370-22-005491-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xelb-20211231.xsd Edgar Link pending
xelb-20211231x10k.htm Edgar Link pending
xelb-20211231x10k_htm.xml Edgar Link completed
xelb-20211231xex10d7.htm Edgar Link pending
xelb-20211231xex21d1.htm Edgar Link pending
xelb-20211231xex23d1.htm Edgar Link pending
xelb-20211231xex23d2.htm Edgar Link pending
xelb-20211231xex31d1.htm Edgar Link pending
xelb-20211231xex31d2.htm Edgar Link pending
xelb-20211231xex32d1.htm Edgar Link pending
xelb-20211231xex32d2.htm Edgar Link pending
xelb-20211231_cal.xml Edgar Link unprocessable
xelb-20211231_def.xml Edgar Link unprocessable
xelb-20211231_lab.xml Edgar Link unprocessable
xelb-20211231_pre.xml Edgar Link unprocessable